title: Successful Etanercept Treatment for Primary Biliary Cirrhosis Associated with Rheumatoid Arthritis.
authors.forename: Attila
authors.initials: A
authors.lastname: Kovács
authors.forename: Adelina G
authors.initials: AG
authors.lastname: Siminischi
authors.forename: Beáta
authors.initials: B
authors.lastname: Baksay
authors.forename: András
authors.initials: A
authors.lastname: Gáll
authors.forename: Mária
authors.initials: M
authors.lastname: Takács
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Szekanecz
mesh_terms: D000368:Aged; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D000068800:Etanercept; D005260:Female; D050823:Hand Joints / Q000473:pathology; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D008105:Liver Cirrhosis, Biliary / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D008111:Liver Function Tests / Q000379:methods; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept